The company said March 17 it is the first U.S. commercial lab to offer the test, which was developed by Immundiagnostik. It detects gluten in a patient’s stool sample.
“Having the ability to confirm and measure unintended gluten exposure gives patients more control over their diets and their health,” Celiac Disease Foundation CEO Marilyn Geller said in the news release. “Labcorp is the first clinical reference lab in the United States to offer a test that utilizes stool samples to directly quantify the disease-triggering source. This new option opens the door for more people across the country to better manage their celiac disease or [non-celiac gluten sensitivity].”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
